Search

everythinglearnresearchcommunity

for

Search:↓

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Lower growth factors linked to balding in androgenetic alopecia.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hair from balding and non-balding areas regrows similarly on mice.

Expert surgeons have a lower rate of hidden damage to hair during hair transplant procedures than beginners.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Androgens can cause hair growth in some areas and hair loss on the scalp.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

New hair transplant method allows for hair regrowth in the donor area and less scarring.